Vaxart Inc (NASDAQ: VXRT) kicked off on Monday, down -7.69% from the previous trading day, before settling in for the closing price of $0.45. Over the past 52 weeks, VXRT has traded in a range of $0.28-$1.07.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1372.05% over the past five years. While this was happening, its average annual earnings per share was recorded 5.52%. With a float of $222.57 million, this company’s outstanding shares have now reached $227.77 million.
Let’s look at the performance matrix of the company that is accounted for 115 employees. In terms of profitability, gross margin is 31.43%, operating margin of -230.99%, and the pretax margin is -232.36%.
Vaxart Inc (VXRT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vaxart Inc is 2.47%, while institutional ownership is 19.84%. The most recent insider transaction that took place on Jun 18 ’24, was worth 13,578. In this transaction Director of this company bought 20,000 shares at a rate of $0.68, taking the stock ownership to the 78,125 shares.
Vaxart Inc (VXRT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.61% during the next five years compared to 17.46% growth over the previous five years of trading.
Vaxart Inc (NASDAQ: VXRT) Trading Performance Indicators
Take a look at Vaxart Inc’s (VXRT) current performance indicators. Last quarter, stock had a quick ratio of 0.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.35, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Vaxart Inc (VXRT)
Vaxart Inc (NASDAQ: VXRT) saw its 5-day average volume 1.47 million, a negative change from its year-to-date volume of 1.91 million. As of the previous 9 days, the stock’s Stochastic %D was 68.58%. Additionally, its Average True Range was 0.04.
During the past 100 days, Vaxart Inc’s (VXRT) raw stochastic average was set at 18.72%, which indicates a significant decrease from 62.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.15% in the past 14 days, which was lower than the 110.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4359, while its 200-day Moving Average is $0.6634. Nevertheless, the first resistance level for the watch stands at $0.4495 in the near term. At $0.4839, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5079. If the price goes on to break the first support level at $0.3911, it is likely to go to the next support level at $0.3671. Assuming the price breaks the second support level, the third support level stands at $0.3327.
Vaxart Inc (NASDAQ: VXRT) Key Stats
The company with the Market Capitalisation of 94.73 million has total of 228,208K Shares Outstanding. Its annual sales at the moment are 28,700 K in contrast with the sum of -66,950 K annual income. Company’s last quarter sales were recorded 15,190 K and last quarter income was -11,990 K.
